Skip to main content
Market intelligence
DTILHealthcare

Precision Biosciences Inc insider activity

In the last 90 days, 3 corporate insiders purchased $29,501 of stock on the open market.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$29,501
Corporate buyers
3
Latest transaction
Sep 28, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Sep 28, 2026Stanley FrankelCorporate insiderOpen Market Purchase1,000$6.00$6,000
Sep 25, 2026Melinda BrownCorporate insiderOpen Market Purchase1,135$6.27$7,116
Sep 25, 2026Geno J GermanoCorporate insiderOpen Market Purchase2,609$6.28$16,385